Karen M. Nichols
Algemeen Adviseur bij International Society for Cellular Therapy
Actieve functies van Karen M. Nichols
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Algemeen Adviseur | 01-01-2007 | - |
Loopbaan van Karen M. Nichols
Eerdere bekende functies van Karen M. Nichols
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MAGENTA THERAPEUTICS | Algemeen Adviseur | - | - |
IMMUNITYBIO, INC. | Algemeen Adviseur | - | - |
Corporate Officer/Principal | - | - |
Opleiding van Karen M. Nichols
The State University of New York | Graduate Degree |
Suffolk University Law School | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Canada | 2 |
Operationeel
General Counsel | 3 |
Graduate Degree | 2 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
NantKwest, Inc.
NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Commercial Services |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Karen M. Nichols
- Ervaring